CN Patent

CN116472266B — 作为脯氨酰羟化酶抑制剂的化合物及其制备方法

Assigned to Jiangsu Suzhong Pharmaceutical Research Institute Co ltd · Expires 2025-05-30 · 1y expired

What this patent protects

提供一种作为脯氨酰羟化酶抑制剂的化合物及其制备方法，属于医药技术领域。所述化合物如式I所示，具有脯氨酰羟化酶抑制活性，可用于治疗由脯氨酰羟化酶活性介导的疾病，如肾性贫血等。

USPTO Abstract

提供一种作为脯氨酰羟化酶抑制剂的化合物及其制备方法，属于医药技术领域。所述化合物如式I所示，具有脯氨酰羟化酶抑制活性，可用于治疗由脯氨酰羟化酶活性介导的疾病，如肾性贫血等。

Drugs covered by this patent

Patent Metadata

Patent number
CN116472266B
Jurisdiction
CN
Classification
—
Expires
2025-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Suzhong Pharmaceutical Research Institute Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.